| 000 -LEADER |
|---|
| fixed length control field |
00659nam a2200193Ia 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20181103164903.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180803s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-81-224-0943-1 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
AIKTC-KRRC |
| Transcribing agency |
AIKTC-KRRC |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
ENG |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Item number |
PAN/DIM |
| Edition number |
DDC23 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Pandey, S. N. |
| 9 (RLIN) |
2704 |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Introduction to drug design |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
New Delhi |
| Name of publisher, distributor, etc. |
New Age |
| Date of publication, distribution, etc. |
1997 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
214, 21.5*13.9 Pages |
| Other physical details |
| Binding - Paperback | |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
The book entitled, An Introduction to Drug Design aims to optimize the discovery of drugs at a low cost and on occasions to change their pharmacokinetic and pharmacodyanamic properties. The introductory chapter which forms the basis of drug discovery is followed by the present-day thinking regarding the best approaches to drug discovery are considered. Similarly, there have been major advances in the employment of computers in structure-activity analysis, and a discussion of the state of the art in this area is also included. The chapter on QSAR highlights the role of physico-chemical parameters in predicting the future course of drug discovery with rational drug design. The role of enzymes in drug action is well established, and a chapter on design of enzyme inhibitors is well documented. In addition, the increased understanding of the design and utilisation of prodrugs has led to a discussion of the relevant issues in this text. Thus the book will fill the need of a text for designing new drugs and the principles of new drug discovery. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
PHARMACEUTICAL CHEMISTRY |
| 9 (RLIN) |
5008 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dimmock, J. R. |
| 9 (RLIN) |
3584 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
https://ndl.iitkgp.ac.in/result?q={%22t%22:%22search%22,%22k%22:%22pharmaceutical%20chemistry%22,%22s%22:[%22DDC=\%22600%3A%3ATechnology\%22%22],%22b%22:{%22filters%22:[]}} |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Text Books |
| Source of classification or shelving scheme |
|
